Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Ablative Fractional 2940 nm Laser Treatment for Lichen Sclerosus Lesion

NCT06389071 is registered in ClinicalTrials.gov with Sciton as lead sponsor.

NCT NCT06389071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06389071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Ablative Fractional 2940 nm Laser Treatment for Lichen Sclerosus Lesion
Lead sponsor
Sciton
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2024
Completion date
December 30, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lichen sclerosus lesion